⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARTL News
Artelo Biosciences, Inc. Common Stock
Form 8-K
sec.gov
ARTL
Form 8-K
sec.gov
ARTL
Artelo Biosciences Announces Reverse Stock Split
globenewswire.com
ARTL
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results
globenewswire.com
ARTL
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
globenewswire.com
ARTL
Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical
globenewswire.com
ARTL
Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results
globenewswire.com
ARTL
Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer
globenewswire.com
ARTL
Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer
globenewswire.com
ARTL
Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit
globenewswire.com
ARTL